(Q67711476)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1724908%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

title

Stage II large B-cell lymphoma with sclerosis treated with MACOP-B (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1724908%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

1 reference

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A057853

9 November 2022

author name string

M. Bertini

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1724908

9 November 2022

L. Orsucci

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1724908

9 November 2022

U. Vitolo

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1724908

9 November 2022

A. Levis

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1724908

9 November 2022

G. Todeschini

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1724908

9 November 2022

V. Meneghini

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1724908

9 November 2022

D. Novero

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1724908

9 November 2022

C. Tarella

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1724908

9 November 2022

E. Gallo

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1724908

9 November 2022

G. Luxi

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1724908

9 November 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1724908

9 November 2022

publication date

1 November 1991

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1724908%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

17 September 2019

http://annonc.oxfordjournals.org/cgi/content/abstract/2/10/733

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1724908

https://api.elsevier.com/content/article/PII:S0923753420315647?httpAccept=text/xml

9 November 2022

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A057853

https://api.elsevier.com/content/article/PII:S0923753420315647?httpAccept=text/plain

9 November 2022

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A057853

http://academic.oup.com/annonc/article-pdf/2/10/733/538550/2-10-733.pdf

9 November 2022

file format

Portable Document Format

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A057853

9 November 2022

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1724908%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

volume

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1724908%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1724908%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

page(s)

733-737

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1724908%20AND%20SRC:MED&resulttype=core&format=json

Diffuse aggressive lymphomas: increased survival after alternating flexible sequences of proMACE and MOPP chemotherapy

17 September 2019

cites work

1

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A057853

COPBLAM III: infusional combination chemotherapy for diffuse large-cell lymphoma

9 November 2022

3

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A057853

MACOP-B chemotherapy for the treatment of diffuse large-cell lymphoma

9 November 2022

5

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A057853

Treatment results with an aggressive chemotherapeutic regimen (MACOP-B) for intermediate- and some high-grade non-Hodgkin's lymphomas

9 November 2022

7

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A057853

Interpretation of clinical trials in diffuse large-cell lymphoma

9 November 2022

8

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A057853

m-BACOD treatment for intermediate- and high-grade malignant lymphomas: a Southwest Oncology Group phase II trial

9 November 2022

9

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A057853

MACOP-B treatment for advanced stage diffuse large cell lymphoma: a multicenter Italian Study

9 November 2022

10

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A057853

Predicting therapeutic outcome in patients with diffuse histiocytic lymphoma treated with cyclophosphamide, adriamycin, vincristine and prednisone (CHOP)

9 November 2022

11

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A057853

Mediastinal diffuse large-cell lymphoma with sclerosis. A clinicopathologic study of 60 cases

9 November 2022

12

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A057853

Mediastinal large-B-cell lymphoma with sclerosis: a clinical study of 21 patients

9 November 2022

13

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A057853

Mediastinal large cell lymphoma. An uncommon subset of adult lymphoma curable with combined modality therapy

9 November 2022

14

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A057853

National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: summary and description of a working formulation for clinical usage. The Non-Hodgkin's Lymphoma Pathologic Classification Project

9 November 2022

15

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A057853

Report of the Committee on Hodgkin's Disease Staging Classification

9 November 2022

16

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A057853

Mediastinal large-cell lymphoma of B-type, with sclerosis: histopathological and immunohistochemical study of eight cases

9 November 2022

17

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A057853

Nonparametric Estimation from Incomplete Observations

9 November 2022

18

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A057853

Primary mediastinal non-Hodgkin's lymphomas: a morphologic and immunologic study of 19 cases

9 November 2022

20

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A057853

Large cell lymphoma of the mediastinum: a B-cell tumour of probable thymic origin

9 November 2022

21

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A057853

Primary large cell lymphoma of the mediastinum. A histologic and immunophenotypic study of 29 cases

9 November 2022

23

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A057853

Mediastinal large-cell lymphoma with sclerosis

9 November 2022

24

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A057853

Clinical features and results of management of superior vena cava syndrome secondary to lymphoma

9 November 2022

25

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A057853

Diffuse histiocytic lymphoma with sclerosis: a clinicopathologic entity frequently causing superior venacaval obstruction.

9 November 2022

26

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A057853

9 November 2022

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1724908%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

1 reference